30 April 2020

Recalls & Warnings for Pharmaceutical Products & Medical Devices

Reference: CIR-2019-00000323

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Recall one batch for pharmaceutical product Mycosat 100000IU-ML oral suspension
• Recall one batch for pharmaceutical products laxocodyl 10mg suppository
• Recall two batch of pharmaceutical product Filter Tips 1500µl
• Recall two batchs of pharmaceutical product Aripiprazole 1mg-ml oral solution
• Recall two batchs of pharmaceutical product Clamox 1g Tablets
• Warning of using medical product Electro Mist

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Recall one batch for pharmaceutical product Mycosat 100000IU-ML oral suspension.pdf:

View Document

Recall one batch for pharmaceutical products laxocodyl 10mg suppository.pdf:

View Document

Recall two batch of pharmaceutical product Filter Tips 1500µl.pdf:

View Document

Recall two batchs of pharmaceutical product Aripiprazole 1mg-ml oral solution.pdf:

View Document

Recall two batchs of pharmaceutical product Clamox 1g Tablets.pdf:

View Document

Warning of using medical product Electro Mist.pdf:

View Document